Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Marks

Showing results (201-210 of 205) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 205 results.
EMBO Molecular Medicine|April 5, 2012
P-selectin genotype is associated with the development of cancer cachexiaBenjamin H L Tan, Torill Fladvad, Theodore P Braun, et al.
Nature Communications|October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
ACS Nano|August 26, 2024
Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 AxisTetiana Korzun, Abraham S Moses, Antony Jozic, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 13, 2022
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated CachexiaTetiana Korzun, Abraham S Moses, Jeonghwan Kim, et al.
ACS Nano|November 21, 2024
Targeting Metastasis in Head and Neck Squamous Cell Carcinoma Using Follistatin mRNA Lipid NanoparticlesVladislav Grigoriev, Tetiana Korzun, Abraham S Moses, et al.
Pageof 21

Showing results (201-210 of 205) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 205 results.
EMBO Molecular Medicine|April 5, 2012
P-selectin genotype is associated with the development of cancer cachexiaBenjamin H L Tan, Torill Fladvad, Theodore P Braun, et al.
Nature Communications|October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
ACS Nano|August 26, 2024
Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 AxisTetiana Korzun, Abraham S Moses, Antony Jozic, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 13, 2022
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated CachexiaTetiana Korzun, Abraham S Moses, Jeonghwan Kim, et al.
ACS Nano|November 21, 2024
Targeting Metastasis in Head and Neck Squamous Cell Carcinoma Using Follistatin mRNA Lipid NanoparticlesVladislav Grigoriev, Tetiana Korzun, Abraham S Moses, et al.
Pageof 21